Rebiotix’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Rebiotix is a biotechnology company that develops microbiota restoration therapies for the treatment of gastrointestinal diseases. Read more

14 Followers on Owler
14 Followers on Owler
14 Followers on Owler
14 Followers on Owler

Rebiotix is a biotechnology company that develops microbiota restoration therapies for the treatment of gastrointestinal diseases. Read more

Lee Jones's photo - President & CEO of Rebiotix

President & CEO

Lee Jones

CEO Approval Rating

89/100

Founded:

2011

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Second Genome is perceived as one of Rebiotix's biggest rivals. Second Genome was founded in 2009, and its headquarters is in Brisbane, California. Like Rebiotix, Second Genome also works within the Biotechnology field. Second Genome has 15 fewer employees than Rebiotix.

Vedanta Biosciences is one of Rebiotix's top rivals. Vedanta Biosciences is a Private company that was founded in 2010 in Cambridge, Massachusetts. Like Rebiotix, Vedanta Biosciences also competes in the Biotechnology sector. Compared to Rebiotix, Vedanta Biosciences has 15 more employees.

Seres Therapeutics is Rebiotix's #3 rival. Seres Therapeutics is a Public company that was founded in Cambridge, Massachusetts in 2010. Like Rebiotix, Seres Therapeutics also operates in the Biotechnology sector. Seres Therapeutics has 38 more employees vs. Rebiotix.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Enterome a competitor of Rebiotix?

Acquisitions

No recent acquisitions found related to Rebiotix

Rebiotix Funding History

$5M$30M$40M

Since Rebiotix was founded in 2011, it has participated in 3 rounds of funding. In total Rebiotix has raised $40.0M. Rebiotix's last funding round was on Aug 2017 for a total of $10.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Aug 2017
$10M
-
Series B
Aug 2014
$25M
-
Series A
Oct 2011
$5M
-

Since Rebiotix was founded in 2011, it has participated in 3 rounds of funding. In total Rebiotix has raised $40.0M. Rebiotix's last funding round was on Aug 2017 for a total of $10.0M

Investments

No recent investments found related to Rebiotix

Rebiotix News

June 26, 20194-traders

Rebiotix Leaders to Discuss Microbiome Product Development Challenges and Regulation at Microbiome Movement - Drug Development Summit 2019

(marketscreener.com) Rebiotix, Inc, a Ferring Pharmaceuticals company, announced today that two membe... See more »
May 17, 2019BioPortfolio

Microbiota Restoration Takes the Podium at DDW 2019 Investigational MicrobiotaBased Therapies for Recurrent C. diff Highlighted

Phase 2 liquid suspension and Phase 1 lyophilized nonfrozen oral capsules containing live microbes we... See more »
March 20, 2019BioPortfolio

Microbiome Health Index Platform to be Presented at Gut Microbiota for Health Summit 2019

Rebiotixs prototype index is under development to measure impact of microbiotabased therapeutics on C... See more »
January 22, 2019PharmiWeb

Ferring, Rebiotix and Karolinska Institutet Extend Collaboration to Research Next Generation of Microbiome Treatments

Ferring, Rebiotix and Karolinska Institutet Extend Collaboration to Research Next Generation of Micro... See more »
October 22, 2018PharmiWeb

Rebiotix Microbiome Health Index Data to be Presented at United European Gastroenterology Annual Conference

Rebiotix Microbiome Health Index Data to be Presented at United European Gastroenterology Annual Conf... See more »
October 9, 2018BioPortfolio

Rebiotix Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250

SummaryRebiotix Inc Rebiotix formerly MikrobEX Inc is a clinical stage biotechnology company that dev... See more »

Rebiotix Press Releases

August 14, 2018PR Newswire

The Microbiome Therapeutics Innovation Group Announces Coalition Formation and Leadership Team

WASHINGTON, Aug. 14, 2018 /PRNewswire/ -- The Microbiome Therapeutics Innovation Group (MTIG) announc... See more »
June 8, 2018PR Newswire

Microbiome Health Index Platform, Outcomes of Rebiotix's RBX7455 Oral Formulation To Be Featured in Rapid Fire and Poster Sessions at ASM Microbe 2018

ROSEVILLE, Minn., June 8, 2018 /PRNewswire/ -- Rebiotix Inc. announced today that findings from Micro... See more »
June 4, 2018PR Newswire

Rebiotix Microbiota Restoration Therapy Products, Microbiome Health Index to Take Center Stage at Digestive Disease Week 2018

ROSEVILLE, Minn., June 4, 2018 /PRNewswire/ -- Rebiotix Inc. announced today that data analyses from ... See more »
June 1, 2018PR Newswire

Rebiotix's President and CEO, Lee Jones to Participate in Microbiome-Focused Panel at the 2018 BIO International Convention

ROSEVILLE, Minn., June 1, 2018 /PRNewswire/ -- Rebiotix Inc. announced today that co-founder, preside... See more »
March 12, 2018ForImmediateRelease

Rebiotix's Chief Scientific Officer, Ken Blount, Ph.D., to Present at Microbiome Therapeutics Europe

Travel & Tourism Industry release: ROSEVILLE, Minn., March 12, 2018 /PRNewswire/ - Rebiotix Inc., a c... See more »
January 9, 2018PR Newswire

Rebiotix Highlights 2017 Achievements and 2018 Objectives

ROSEVILLE, Minn., Jan. 9, 2018 /PRNewswire/ -- Rebiotix Inc., a clinical-stage microbiome company foc... See more »
January 5, 2018StreetInsider

Rebiotix and CoreBiome Collaborate on Evaluating Microbiomes of Patients Treated with Microbiota Restoration Therapy

Rebiotix Inc., a clinical-stage microbiome company focused on harnessing the power of the human micro... See more »

Rebiotix Videos

Social Media

Headquarters

2660 Patton Road

Roseville, Minnesota55113

651-705-8772

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Rebiotix is a biotechnology company that develops microbiota restoration therapies for the treatment of gastrointestinal diseases. Rebiotix was founded in 2011. Rebiotix's headquarters is located in Roseville, Minnesota, USA 55113. It has raised 40.0M...

CEO

Rebiotix's President & CEO, Lee Jones, currently has an approval rating of 89%. Rebiotix's primary competitors are Second Genome, Vedanta Biosciences & Seres Therapeutics.

Website

rebiotix.com

Frequently Asked Questions about Rebiotix

  1. When was Rebiotix founded?

    Rebiotix was founded in 2011
  2. Who is Rebiotix's CEO?

    Rebiotix's CEO is Lee Jones
  3. How much revenue does Rebiotix generate?

    Rebiotix generates $2.9M in revenue
  4. How much funding does Rebiotix have?

    Rebiotix has historically raised $40M in funding
  1. Where is Rebiotix's headquarters?

    Rebiotix's headquarters is in Roseville Minnesota, USA
  2. How many employees does Rebiotix have?

    Rebiotix has 70 employees
  3. What sector does Rebiotix operate in?

    Rebiotix is in Biotechnology
  4. Who are Rebiotix's competitors?

    Rebiotix's top competitors are Second Genome, Vedanta Biosciences, Seres Therapeutics